6-(4-((6-ChloroH-imidazo[1,2-a]pyridin-2-yl)methyl)piperazin-1-yl)nicotinonitrile

ID: ALA3092413

PubChem CID: 73211886

Product Number: C608887, Order Now?

Max Phase: Preclinical

Molecular Formula: C18H17ClN6

Molecular Weight: 352.83

Molecule Type: Small molecule

In stock!

Associated Items:

Names and Identifiers

Canonical SMILES:  N#Cc1ccc(N2CCN(Cc3cn4cc(Cl)ccc4n3)CC2)nc1

Standard InChI:  InChI=1S/C18H17ClN6/c19-15-2-4-18-22-16(13-25(18)11-15)12-23-5-7-24(8-6-23)17-3-1-14(9-20)10-21-17/h1-4,10-11,13H,5-8,12H2

Standard InChI Key:  UGDJVSURAKMIPU-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
    1.5463   -3.8754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5451   -4.6950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2532   -5.1039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9629   -4.6945    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9600   -3.8718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2514   -3.4666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2535   -5.9162    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5439   -6.3234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5418   -7.1370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2476   -7.5496    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9572   -7.1424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9610   -6.3226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2443   -8.3668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9503   -8.7782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0362   -9.5870    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7019   -8.4446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2463   -9.0540    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8326   -9.7576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2350  -10.4656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0510  -10.4712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4629   -9.7629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0581   -9.0578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2493   -2.6535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2469   -1.8363    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2822   -9.7665    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  1  0
  7 12  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  3  7  1  0
 10 13  1  0
 13 14  1  0
 14 15  1  0
 15 18  2  0
 17 16  1  0
 16 14  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 23 24  3  0
  6 23  1  0
 21 25  1  0
M  END

Associated Targets(Human)

GPR39 Tchem G-protein coupled receptor 39 (216 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3B Tclin Phosphodiesterase 3B (312 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Gpr39 Protein Gpr39 (9 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 352.83Molecular Weight (Monoisotopic): 352.1203AlogP: 2.58#Rotatable Bonds: 3
Polar Surface Area: 60.46Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.12CX LogP: 2.36CX LogD: 2.34
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.72Np Likeness Score: -3.10

References

1. Boehm M, Hepworth D, Loria PM, Norquay LD, Filipski KJ, Chin JE, Cameron KO, Brenner M, Bonnette P, Cabral S, Conn E, Ebner DC, Gautreau D, Hadcock J, Lee EC, Mathiowetz AM, Morin M, Rogers L, Smith A, VanVolkenburg M, Carpino PA..  (2013)  Chemical Probe Identification Platform for Orphan GPCRs Using Focused Compound Screening: GPR39 as a Case Example.,  (11): [PMID:24900608] [10.1021/ml400275z]
2. Burley R, Hewer RC, Teall M, Dickson L, Ossola B, Russell S, Bender C, Cheung T, Powell JAC, Xu X, Brice NL, Otter L, Arimont M, Kidd SL, Vidal D, Dale JW, Mervin L, Sore HF, Mateu N, Lakshminarayana N, Dawson LA, Carlton M, Bürli RW..  (2022)  Synthesis and SAR of novel GPR39 agonists and positive allosteric modulators.,  61  [PMID:35123006] [10.1016/j.bmcl.2022.128607]

Source